News

Endpoints News
endpoints. news > sino-biopharm-hooks-astrazeneca-gsk-for-separate-respiratory-partnerships

Sino Biopharm hooks Astra Zeneca, GSK for separate respiratory partnerships

6+ hour, 55+ min ago  (49+ words) Endpoints News Sino Bio'pharm hooks As'tra Zeneca, GSK for sep'a'rate res'pi'ra'to'ry part'ner'ships Sino Bio'phar'ma'ceu'ti'cal an'nounced drug de'vel'op'ment and sales pacts with two UK phar'ma com'pa'nies on Wednes'day. Think we're worth reading - tell Google. Confirm Endpoints as a trusted biopharma news…...

Symbols: btc-usd,lse:azn
Endpoints News
endpoints. news > biohaven-looks-to-take-on-lilly-in-the-muscle-sparing-obesity-space

Biohaven looks to take on Lilly in the muscle-sparing obesity space

3+ hour, 25+ min ago  (65+ words) Endpoints News Bio'haven looks to take on Lil'ly in the mus'cle-spar'ing obe'si'ty space They say that the way to make mon'ey in a gold rush is to open a shop sell'ing picks and shov'els. By the same to'ken " Think we're…...

Symbols: nyse:lly
Endpoints News
endpoints. news > sanofi-offers-to-end-disparaging-claims-against-csl-flu-shot-in-europe

After government probe, Sanofi offers to end disparaging claims against CSL flu shot in Europe

2+ hour, 38+ min ago  (72+ words) Endpoints News Af'ter gov'ern'ment probe, Sanofi of'fers to end dis'parag'ing claims against CSL flu shot in Eu'rope Two weeks af'ter the Eu'ro'pean Com'mis'sion launched an in'ves'ti'ga'tion in'to Sanofi, the French drug'mak'er has of'fered to stop mak'ing neg'a'tive claims about a…...

Symbols: btc-usd
Endpoints News
endpoints. news > novartis-cuts-new-jersey-jobs-otr-lg-chem-explore-china-cancer-drugs

Novartis cuts New Jersey jobs; OTR, LG Chem explore China cancer drugs

3+ hour, 21+ min ago  (38+ words) Endpoints News No'var'tis cuts New Jer'sey jobs; OTR, LG Chem ex'plore Chi'na can'cer drugs Plus news about Seres, Bio'cy'to'gen, White'hawk, Boehringer In'gel'heim, Prime Vec'tor and Min'd Rank....

Symbols: btc-usd,nyse:nvs
Endpoints News
endpoints. news > satellos-early-look-at-duchenne-pill-in-adults-ahead-of-key-data-in-children

Satellos gives early look at Duchenne pill in adults ahead of key data in children

7+ hour, 21+ min ago  (71+ words) Endpoints News Satel'los gives ear'ly look at Duchenne pill in adults ahead of key da'ta in chil'dren Satel'los Bio'science is build'ing its case for a Duchenne mus'cu'lar dy's'tro'phy pill with da'ta in adult pa'tients ahead of a po'ten'tial'ly piv'otal read'out…...

Symbols: nasdaq:rgnx,six:sann
Endpoints News
endpoints. news > how-digital-health-companies-are-planning-to-conquer-cms-access

How digital health companies are planning to conquer a brand new Medicare experiment

1+ day, 4+ hour ago  (67+ words) Endpoints News How dig'i'tal health com'pa'nies are plan'ning to con'quer a brand new Medicare ex'per'i'ment A new Medicare ex'per'i'ment to man'age se'niors" chron'ic dis'eases will pay some dig'i'tal health com'pa'nies on'ly about as much in a year as they might…...

Symbols: btc-usd,d05.S0,u11.S0,z74.S0,a31.S0
Endpoints News
endpoints. news > cms-proposes-340b-cuts

CMS proposes 340 B cuts

1+ day, 23+ hour ago  (49+ words) Endpoints News CMS pro'pos'es 340 B cuts A pro'posed rule would cut the rates by which Medicare pays hos'pi'tals for 340 B drugs by more than a third, re'viv'ing a sim'i'lar pol'i'cy in'tro'duced " Think we're worth reading - tell Google. Confirm Endpoints as…...

Symbols: nyse:cms
Endpoints News
endpoints. news > fda-approves-23-new-drugs-in-first-half-overcoming-staff-cut-concerns

FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years

2+ day, 24+ min ago  (76+ words) Endpoints News FDA ap'provals out'run staff cuts: 23 nov'el drugs mark the best first half in three years There's an an'swer emerg'ing on the multi'bil'lion-dol'lar ques'tion of whether the Trump ad'min'is'tra'tion's gut'ting of FDA staff in April 2025 would slow down drug…...

Symbols: nyse:lly,achr-ab,asx:tlx
Endpoints News
endpoints. news > new-cder-appointment-elevates-longtime-glp-1-reviewer

New acting deputy CDER promotion elevates longtime GLP-1 reviewer

2+ day, 46+ min ago  (61+ words) Endpoints News New act'ing deputy CDER pro'mo'tion el'e'vates long'time GLP-1 re'view'er Act'ing FDA CDER di'rec'tor Michael Davis has pro'mot'ed a long'time FDA staffer as an act'ing deputy di'rec'tor at the drug cen'ter. Lisa Yanoff, an agency " Think we're worth reading…...

Endpoints News
endpoints. news > sp > honeybear-biosciences-bringing-total-funds-raised-to-34-million-to-accelerate-lead-radiopharmaceutical-candidates-into-clinical-trial

Honeybear Biosciences Bringing Total Funds Raised to $34 Million to Accelerate Lead Radiopharmaceutical Candidates into Clinical Trial

2+ day, 8+ hour ago  (492+ words) Endpoints News Hon'ey'bear Bio'sciences Bring'ing To'tal Funds Raised to $34 Mil'lion to Ac'cel'er'ate Lead Ra'dio'phar'ma'ceu'ti'cal Can'di'dates in'to Clin'i'cal Tri'al Hon'ey'bear Bio'sciences Inc. an'nounces the com'ple'tion of a US $20 mil'lion Se'ries A fi'nanc'ing round, bring'ing the to'tal cap'i'tal raised to US $34 mil'lion,…...

Symbols: nasdaq:gtbp